Unitary Patent and the UPC: 7 Smart Choices for 2026

A European patent grant lands on your desk, and you have about four weeks to make a decision that affects coverage and cost for the next two decades. Since 1 June 2023, the Unitary Patent has offered a single patent right across most of the European Union, enforced by one new court. It is the biggest shift in European patent practice in 50 years, and the defaults are unforgiving: miss a one-month window and the option is gone. This guide walks you through how the system works, what it costs, and how to choose between a Unitary Patent and the classic route you already know.

What the Unitary Patent Changed in 2023

You still file and prosecute at the European Patent Office exactly as before. The change happens after grant. Instead of validating your granted European patent country by country, you can request “unitary effect” and get a single right, the Unitary Patent, covering every participating member state at once.

As of 2026, 18 EU countries participate, including Germany, France, Italy and the Netherlands, according to the European Patent Office. Several big markets sit outside it. Spain and Poland chose not to join, Croatia has not signed up, and non-EU countries such as the United Kingdom, Switzerland, Norway and Turkey were never part of it. So the new right is broad, but it is not “all of Europe.”

One nuance trips people up: unitary effect only covers the states where the underlying agreement was in force on the day it was registered. Patents registered early in the system cover 17 states and do not stretch to add a later joiner. Confirm the exact country list for your registration date rather than assuming the current maximum, because the participating-state map is still expanding.

How You Get One: The One-Month Deadline

To obtain unitary effect you file a request with the EPO no later than one month after the date the grant is mentioned in the European Patent Bulletin. This period is not extendable, so it has to be diarised the moment the grant decision issues.

During a transitional period of at least six years, the request also needs one full translation of the specification. If your patent was granted in French or German, you translate it into English. If it was granted in English, you translate it into any other official EU language. The translation is for information only, but without it the request is incomplete.

1. Watch for the mention of grant in the European Patent Bulletin, which starts the one-month clock.
2. Decide unitary effect versus classic national validation before that clock runs out.
3. File the request for unitary effect with the required translation inside the one-month window.
4. For countries outside the system (UK, Spain, Switzerland, and others you care about), arrange separate national validation in parallel.

Inside the UPC: Jurisdiction and Central Revocation Risk

Every patent with unitary effect is litigated in the Unified Patent Court (UPC). The Court of First Instance has a Central Division seated in Paris, Munich and Milan, plus local and regional divisions across member states, with a Court of Appeal in Luxembourg. Local and regional divisions hear infringement actions; the central division handles standalone revocation and declarations of non-infringement.

The upside is obvious: one infringement action can deliver an injunction across all participating states at once. The downside is the mirror image. A single revocation action can knock the right out everywhere it applies. That central point of failure is the strategic heart of the whole decision, and it is why some patentees still prefer the older, country-by-country approach for their most valuable inventions. Before you litigate or defend, a solid patent invalidity search tells you how exposed that single right really is.

The Cost Story: One Renewal Fee

Renewal economics are where the new route earns its keep. Instead of paying separate annuities to each national office through local agents, you pay one annual renewal fee to the EPO that covers all participating states. The fee was set on a “True Top 4” basis, roughly equivalent to the combined renewal fees of the four countries where European patents were most often validated, so the savings scale with how many markets you would otherwise cover.

The practical rule of thumb: unitary effect tends to pay off when you would otherwise validate and maintain in around four or more participating countries. If you only want protection in one to three markets, classic national validation is usually cheaper because you pay only where you actually validate. Run the numbers against the current EPO fee schedule before you commit, since the figures change, and remember that a missed renewal payment can lapse the right everywhere at once.

You also save on the administrative drag: a single renewal payment instead of a spreadsheet of national deadlines, translations and local-agent invoices. For a lean in-house team, that simplicity has real value. Many companies still pair it with disciplined patent annuity and renewal management for the non-participating countries they validate separately.

The Opt-Out Decision, Explained

Here is a point that confuses almost everyone. The famous “opt-out” does not apply to unitary patents at all. A patent with unitary effect is always under the UPC, full stop. The opt-out is only available for classic, nationally validated European patents during the transitional period.

That transitional period runs for seven years from June 2023 and can be extended by up to a further seven years. During it, holders of classic European patents can opt out of the UPC, which keeps validity and infringement disputes in the national courts and away from central revocation. Opting out is free, and it generally lasts for the life of the patent. You can withdraw the opt-out once, unless national litigation has already started.

So the real choice for a strong, high-value invention is often a three-way one: take unitary effect and accept central jurisdiction, validate classically and opt out to avoid it, or build a hybrid portfolio that does both across different patents. The right answer depends less on the technology than on how badly you would be hurt if a competitor revoked the patent in a single stroke.

A Decision Framework for Startups and Counsel

Strip away the jargon and the choice comes down to three questions: which markets do you actually need, what is your budget over the patent’s life, and how much central revocation risk can you stomach?

• Need broad EU coverage and want one renewal fee and one enforcement action? Unitary effect is usually the efficient pick.
• Only care about one to three markets? Classic national validation is typically cheaper and avoids central revocation exposure.
• Have a crown-jewel patent you cannot risk losing everywhere at once? Validate classically and opt out during the transitional period.
• Run a mixed portfolio? Use the unitary route for the core and add national validations for the UK, Spain, Switzerland and other non-participating markets.

Most real portfolios end up hybrid, because no single route covers the UK, Switzerland or Spain. Decide patent by patent, not as a blanket policy, and revisit the call as the participating-state list grows. A startup with one key product in Germany and France may lean one way; a medtech company selling across the bloc and the UK will almost always need a blended approach.

Key Deadlines and a Pre-Decision Checklist

The new system rewards preparation and punishes drift. By the time grant issues, you want the decision already modelled so you are simply executing, not scrambling inside a one-month window.

1. Map your true target markets and flag which ones sit outside the system (UK, Spain, Switzerland, and others).
2. Model the cost of unitary effect versus classic validation over the full patent term.
3. Decide your UPC posture early: unitary, classic-and-opt-out, or hybrid.
4. Diarise the mention of grant and the one-month request deadline the instant the grant decision arrives.
5. Confirm the current participating-state list and fee schedule with your attorney before filing.

If your invention is also heading to the United States, coordinate the European call with your US strategy. Our explainer on USPTO vs EPO patent requirements is a useful companion read.

How PerspireIP Can Help

Choosing between a Unitary Patent, classic validation and an opt-out is a portfolio decision with real money attached. PerspireIP helps founders and in-house teams model the cost, map coverage gaps, and hit the post-grant deadlines without surprises. Talk to our team before your next European grant issues.

Frequently Asked Questions